116 related articles for article (PubMed ID: 35758385)
21. [Efficacy and prognosis of different treatments on 63 patients with small intestinal gastrointestinal stromal tumors].
Liu L; Liu Y; Wu X; Chen L; Xu W
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):344-7. PubMed ID: 24760642
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
24. A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST).
Liu X; Qiu H; Wu Z; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
J Gastrointest Surg; 2018 Dec; 22(12):2150-2157. PubMed ID: 30030719
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.
Shi HP; Huang ML; Wang ZQ; Zheng YN; Zhu ZL; Sah BK; Liu WT; Yan M; Zhu ZG; Li C
Dig Surg; 2018; 35(6):498-507. PubMed ID: 29232679
[TBL] [Abstract][Full Text] [Related]
26. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
27. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
28. Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.
Machado NO; Chopra PJ; Al-Haddabi IH; Al-Qadhi H
JOP; 2011 Mar; 12(2):194-9. PubMed ID: 21386652
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.
Zhao WY; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Cao H; Zhang ZG
BMC Gastroenterol; 2014 Jun; 14():105. PubMed ID: 24906683
[TBL] [Abstract][Full Text] [Related]
30. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
Yang W; Liu Q; Lin G; Zhang B; Cao H; Zhao Y; Xia L; Feng F; Xiong Z; Hu J; Ye Y; Tao K; Zhang P
J Surg Oncol; 2021 Dec; 124(7):1128-1135. PubMed ID: 34324197
[TBL] [Abstract][Full Text] [Related]
31. Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors.
Varshney VK; Gupta RK; Saluja SS; Tyagi I; Mishra PK; Batra VV
Indian J Cancer; 2019; 56(2):135-143. PubMed ID: 31062732
[TBL] [Abstract][Full Text] [Related]
32. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376
[TBL] [Abstract][Full Text] [Related]
35. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China].
Qiu H; Zhang P; Feng X; Chen T; Sun X; Yu J; Chen Z; Li Y; Tao K; Li G; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1265-1270. PubMed ID: 27928797
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients.
Caterino S; Lorenzon L; Petrucciani N; Iannicelli E; Pilozzi E; Romiti A; Cavallini M; Ziparo V
World J Surg Oncol; 2011 Feb; 9():13. PubMed ID: 21284869
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stromal tumors of the duodenum: surgical management and survival results.
Liang X; Yu H; Zhu LH; Wang XF; Cai XJ
World J Gastroenterol; 2013 Sep; 19(36):6000-10. PubMed ID: 24106400
[TBL] [Abstract][Full Text] [Related]
39. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
40. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival.
Xu SJ; Zhang SY; Dong LY; Lin GS; Zhou YJ
BMC Cancer; 2021 Nov; 21(1):1170. PubMed ID: 34724907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]